| Identification | Back Directory | [Name]
1,5-Benzoxazepin-4(5H)-one, 2,3-dihydro-5-methyl-3-[2,4,5,7-tetrahydro-7-oxo-2-(phenylmethyl)-6H-pyrazolo[3,4-c]pyridin-6-yl]-, (3S)- | [CAS]
2095514-75-1 | [Synonyms]
TP-030-1
1,5-Benzoxazepin-4(5H)-one, 2,3-dihydro-5-methyl-3-[2,4,5,7-tetrahydro-7-oxo-2-(phenylmethyl)-6H-pyrazolo[3,4-c]pyridin-6-yl]-, (3S)- | [Molecular Formula]
C23H22N4O3 | [MOL File]
2095514-75-1.mol | [Molecular Weight]
402.45 |
| Hazard Information | Back Directory | [Uses]
TP-030-1 is an inhibitor of RIPK1. TP-030-1 inhibits hRIPK1 with a Ki value of 3.9 nM and inhibits mRIPK1 with an IC50 value of 4.2 μM. TP-030-1 can be used for the research of inflammatory diseases and neurodegenerative diseases[1]. | [References]
[1] Msato Yoshikawa, et al. Discovery of 7-Oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure–Kinetic Relationships. J. Med. Chem. 2018, 61, 6, 2384–2409. |
|
|